Author
Jessica Oi‐Ling Tsang
Also Known As
Jessica O.L. Tsang, Jessica Oi-Ling Tsang, Jessica Oi‐Ling Tsang
25
Publications
1.9K
Citations
15
H-Index
29
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 7 | 7 | 560 |
2 | Immunology | 5 | 5 | 366 |
3 | Health Sciences | 1 | 1 | 61 |
4 | Cell Biology | 1 | 1 | 36 |
5 | Microbiology | 1 | 1 | 123 |
Jessica Oi‐Ling Tsang
×
16
Publications
1.9K
Citations
15
H-Index
| Year | Citations | |
|---|---|---|
2020 | 829 | |
2022 | 215 | |
2016 | 186 | |
2017 | 123 | |
2016 | 116 | |
Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system Shuofeng Yuan, Jasper Fuk‐Woo Chan, Kenn Ka-Hang Chik, Drug SafetyFda-approved Drugs BexarotenePreclinical Drug EvaluationMedicineAntiviral Therapy | 2020 | 71 |
2022 | 61 | |
2022 | 49 | |
2017 | 40 | |
2019 | 36 |
Page 1
Page 1